Ruwan Gunaratne

Title: Ruwan Gunaratne: Innovator in Cancer Treatment

Introduction

Ruwan Gunaratne is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of polycationic polymers. His work aims to improve methods for treating and detecting cancer, showcasing his commitment to advancing medical science.

Latest Patents

Ruwan Gunaratne holds a patent for "Polycationic polymers for use in treating and detecting cancer." This patent outlines methods of treating cancer in a subject by administering a therapeutically effective amount of a polycationic polymer. Additionally, it describes methods for detecting cancer or metastasis by analyzing bodily fluids for circulating free DNA (cfDNA), cfRNA, inorganic polyphosphates, or the number of exosomes or nucleosomes present in the sample. This innovative approach has the potential to enhance cancer diagnostics and treatment strategies.

Career Highlights

Ruwan Gunaratne is affiliated with Duke University, where he continues to conduct research and develop new methodologies in cancer treatment. His dedication to scientific inquiry and innovation has positioned him as a valuable asset in the medical research community.

Collaborations

Ruwan collaborates with Ibtehaj Naqvi, working together to advance their research initiatives and contribute to the field of cancer treatment.

Conclusion

Ruwan Gunaratne's work in developing polycationic polymers represents a significant advancement in cancer treatment and detection. His innovative approaches and dedication to research continue to inspire progress in the medical field.